2018 Plenary Sessions
Constitution A&B

MONDAY, AUGUST 20

4:15 pm Chairperson’s Remarks

Mathews CharlesCharles Mathews, Principal, ClearView Healthcare Partners


4:25 - 5:45 pm Global Dx Insights: Policy and Prediction for Diagnostics

Schott CeciliaModerator: Cecilia Schott, PhD, Former Vice President, Precision Medicine, AstraZeneca


  • Will value-based medicine replace fee-for-service?
  • PAMA impact on reimbursement
  • Changes in LDT oversight policy
  • Changing landscape of IVD regulation in U.K. and Europe after Brexit
  • What is the future of molecular diagnostics in medical care?
  • How will these policy changes affect the patient?

Panelists:

Dietzen DennisDennis J. Dietzen, PhD, DABCC, FAACC, President, AACC; Professor of Pathology & Immunology and Pediatrics, Washington University School of Medicine; Medical Director of Laboratory Services, St. Louis Children’s Hospital


Leite JohnJohn Leite, PhD, Vice President, Strategic Partnerships, Corporate and Business Development, Illumina


Lichtenfeld LeonardJ. Leonard Lichtenfeld, MD, MACP, Deputy CMO, American Cancer Society, Inc.


Pratt VictoriaVictoria M. Pratt, PhD, FACMG, Director, Pharmacogenomics and Molecular Genetics Laboratories, Department of Medical and Molecular Genetics, Indiana University School of Medicine (AMP President-Elect)


VanMeter SusanSusan Van Meter, Executive Director, AdvaMedDx


Young IanIan S. Young, MD, PhD, Chief Scientific Advisor, Department of Health (Northern Ireland) and President, Association for Clinical Biochemistry and Laboratory Medicine (ACB), UK


THURSDAY, AUGUST 23, 2018

11:15 am Chairperson’s Remarks

11:20 am - 12:00 pm TECHNOLOGY PANEL: Disruptive Technologies in Lab Medicine

Tsongalis GregoryModerator: Gregory J. Tsongalis, PhD, HCLD, CC, Professor, Pathology; Director, Laboratory for Clinical Genomics and Advanced Technology (CGAT), Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center and The Audrey and Theodor Geisel School of Medicine at Dartmouth


  • What is appropriate test utilization?
  • How do you ensure both user and patient safety?
  • How are tests implemented in the clinical setting?
  • How do they get regulated?
  • How do results get reported?
  • How do you enforce quality control in implementation?
  • How does it impact emerging applications such as liquid biopsies, infectious disease outbreaks, and POC diagnostics?

Panelists:

Nagarajan RakeshRakesh Nagarajan, MD, PhD, Chief Biomedical Informatics Officer, PierianDx


Richard_GregGreg Richard, Chief Commercial Officer, Interpace Diagnostics


Icenhour_CrystalCrystal R. Icenhour, PhD, CEO, Aperiomics, Inc.


Additional Panelists to be Announced

12:00 - 12:45 pm Changing Approaches to Sustainable Funding in Diagnostics

Quinn BruceModerator: Bruce Quinn, MD, PhD, Principal, Bruce Quinn Associates

Today, many innovators in the diagnostics industry struggle for funding, and yet news of large scale acquisitions or large (over $30M) funding rounds pops up regularly. How can innovators better understand the changing dynamics of the funding environment to succeed? How can investors know if they are getting exposed to the potentially best investments? Whether government or private, what drives the final difficult decisions and how can companies raise their chances of success? This session features leaders from several different channels of funding for innovators, including the NIH, other federal programs, and corporate and traditional venture investors.

Panelists:

DeWinter AlexAlex DeWinter, PhD, Managing Director, GE Ventures


Merkeley TylerTyler Merkeley, BARDA’s CARB-X Program Manager, Health Scientist, Division of CBRN Countermeasures, BARDA


Haim ToddTodd Haim, PhD, Program Director, National Cancer Institute SBIR Development Center


Meuleman WouterWouter Meuleman, PhD, Director, Venture Investments, Illumina Ventures


David_SansDavid Sans, PhD, MBA, F.A.A.R.M., Managing Director, Healthcare Capital Markets, THINK EQUITY (A Division of Fordham Financial Mgmt., Inc.)




Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  


Premier Sponsor

Boston Healthcare logo(1)  

Register Now

 

Download 2018 Brochure

 

Conference At A Glance